The fact that GM did not affect how brain functional organization modulates the impact of insulin resistance on PI performance reinforces the notion that APOE ε4 carriers and individuals with insulin resistance rely on different neural pathways to mitigate deficits in key regions responsible for PI processes. The gene discussed is APOE; the disease is Insulin resistance.